In agreement with the TCGA LUSC cohort, 9 of the 25 (36%) LUSC patients from the TRACERx-100 cohort expressed HERVH-CALB1 at greater than 1 TPM in 1 or more tumor regions (Figure 4E). The gene discussed is CALB1; the disease is neoplasm.